US Patent Issued to EvviVax on May 12 for "Consensus sequence of the antigen telomerase and the use thereof in preventive and therapeutic vaccination" (Italian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,955, issued on May 12, was assigned to EvviVax S.r.l. (Rome).

"Consensus sequence of the antigen telomerase and the use thereof in preventive and therapeutic vaccination" was invented by Luigi Aurisicchio (Rome) and Antonella Conforti (Rome).

According to the abstract* released by the U.S. Patent & Trademark Office: "A consensus sequence of the antigen telomerase (ConTRt) can be generated and used in preventive and therapeutic vaccination. The consensus sequence of telomerase was generated by the fusion of two sequences, one belonging to human telomerase (hTERT) and the other to dog telomerase (dTERT), with the aim of developing an effective vaccine for the treatment of tumors exp...